SI1458853T1 - Postopki donorsko specifiŽŤnega navzkriĹľnega ujemanja - Google Patents

Postopki donorsko specifiŽŤnega navzkriĹľnega ujemanja

Info

Publication number
SI1458853T1
SI1458853T1 SI200331742T SI200331742T SI1458853T1 SI 1458853 T1 SI1458853 T1 SI 1458853T1 SI 200331742 T SI200331742 T SI 200331742T SI 200331742 T SI200331742 T SI 200331742T SI 1458853 T1 SI1458853 T1 SI 1458853T1
Authority
SI
Slovenia
Prior art keywords
methods
donor specific
crossmatching
specific crossmatching
donor
Prior art date
Application number
SI200331742T
Other languages
English (en)
Slovenian (sl)
Inventor
Suchitra Sumitran-Holgersson
Original Assignee
Absorber Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absorber Ab filed Critical Absorber Ab
Publication of SI1458853T1 publication Critical patent/SI1458853T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
SI200331742T 2002-05-16 2003-05-16 Postopki donorsko specifiŽŤnega navzkriĹľnega ujemanja SI1458853T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38103302P 2002-05-16 2002-05-16
EP03730427A EP1458853B1 (en) 2002-05-16 2003-05-16 Methods of donor specific crossmatching
PCT/IB2003/002502 WO2003098212A2 (en) 2002-05-16 2003-05-16 Method of isolating an endotehelial cell and method of donor specific crossmatching

Publications (1)

Publication Number Publication Date
SI1458853T1 true SI1458853T1 (sl) 2010-04-30

Family

ID=29550055

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331742T SI1458853T1 (sl) 2002-05-16 2003-05-16 Postopki donorsko specifiŽŤnega navzkriĹľnega ujemanja

Country Status (17)

Country Link
US (3) US8173372B2 (https=)
EP (1) EP1458853B1 (https=)
AT (1) ATE449838T1 (https=)
AU (1) AU2003241107B2 (https=)
BR (1) BRPI0311182A2 (https=)
CA (1) CA2486119C (https=)
CY (1) CY1109815T1 (https=)
DE (1) DE60330223D1 (https=)
DK (1) DK1458853T3 (https=)
ES (1) ES2337244T3 (https=)
IL (2) IL165250A0 (https=)
NO (1) NO20040174L (https=)
NZ (1) NZ537220A (https=)
PL (2) PL212661B1 (https=)
PT (1) PT1458853E (https=)
SI (1) SI1458853T1 (https=)
WO (1) WO2003098212A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
DK1458853T3 (da) * 2002-05-16 2010-04-06 Absorber Ab Fremgangsmåde til donorspecifik krydsmatchning
EP2041299A4 (en) 2006-07-14 2010-01-13 Aviva Biosciences Corp METHOD AND COMPOSITIONS FOR DETECTION OF RARE CELLS FROM A BIOLOGICAL SAMPLE
EP2051076A1 (en) * 2007-10-18 2009-04-22 Koninklijke Philips Electronics N.V. Interaction of probe molecules and cells as a diagnostic marker
BR112022014417A2 (pt) 2020-01-24 2022-09-13 Pfizer Anticorpos anti-e-selectina, composições e métodos de uso

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4965204A (en) 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5130144B1 (en) 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US5026365A (en) 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
ATE81724T1 (de) 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
ATE156344T1 (de) 1991-04-25 1997-08-15 Univ Brown Res Found Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
US5257984A (en) 1991-10-02 1993-11-02 Norfolk Scientific, Inc. Blood collector
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
AU672775B2 (en) 1992-01-21 1996-10-17 Cobe Laboratories Inc. Method of freezing cells and cell-like materials
US5518890A (en) 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
SG48813A1 (en) 1993-08-12 1998-05-18 Cytotherapeutics Inc Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5482841A (en) 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
KR0176513B1 (ko) * 1995-04-13 1999-04-15 김광호 자기 기록/재생장치
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
AU4659697A (en) 1996-10-03 1998-04-24 Regents Of The University Of California, The Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US20030100107A1 (en) 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
US6376653B1 (en) 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US6309643B1 (en) 1999-04-30 2001-10-30 The Regents Of The University Of California IBD-associated microbial antigens and methods of using same
GB0015923D0 (en) * 2000-06-30 2000-08-23 Astrazeneca Ab Methods
US6984308B2 (en) * 2001-03-06 2006-01-10 Cincinnati Children's Hospital Research Foundation Electrochemical analysis of coenzyme Q10 and reduced coenzyme Q10
US20050026220A1 (en) 2001-08-10 2005-02-03 Shahin Rafii Isolation and mobilization of stem cells expressing vegfr-1
WO2003062373A2 (en) * 2001-10-18 2003-07-31 The Children's Hospital Of Philadelphia Methods and materials for the recruitment of endothelial cells
DK1458853T3 (da) * 2002-05-16 2010-04-06 Absorber Ab Fremgangsmåde til donorspecifik krydsmatchning
CA2574186A1 (en) * 2004-08-13 2006-02-23 Medtronic, Inc. Isolation of endothelial progenitor cell subsets and methods for their use

Also Published As

Publication number Publication date
WO2003098212A2 (en) 2003-11-27
PL397820A1 (pl) 2012-07-16
NZ537220A (en) 2008-06-30
AU2003241107A1 (en) 2003-12-02
DK1458853T3 (da) 2010-04-06
US20090142780A1 (en) 2009-06-04
US8034635B2 (en) 2011-10-11
IL165250A0 (en) 2005-12-18
CA2486119C (en) 2011-01-04
AU2003241107B2 (en) 2009-09-03
BRPI0311182A2 (pt) 2016-06-21
ES2337244T3 (es) 2010-04-22
EP1458853B1 (en) 2009-11-25
ATE449838T1 (de) 2009-12-15
EP1458853A2 (en) 2004-09-22
PL373564A1 (en) 2005-09-05
DE60330223D1 (https=) 2010-01-07
US8173372B2 (en) 2012-05-08
US20030228638A1 (en) 2003-12-11
NO20040174L (no) 2004-03-08
CA2486119A1 (en) 2003-11-27
WO2003098212B1 (en) 2004-07-29
US20050244404A1 (en) 2005-11-03
WO2003098212A3 (en) 2004-07-01
CY1109815T1 (el) 2014-09-10
PT1458853E (pt) 2010-02-23
PL212661B1 (pl) 2012-11-30
IL165250A (en) 2011-03-31

Similar Documents

Publication Publication Date Title
IL169604A0 (en) Dual expression vector system for antibody expression in bacterial and mammalian cells
EP1660653A4 (en) BIODEGRADABLE POLYMER-LIGAND CONJUGATES AND THEIR USES IN THE ISOLATION OF CELLULAR SUB-POPULATIONS AND IN THE CYNOSINATION, CULTURE AND TRANSPLANTATION OF CELLS
EP2471905A3 (en) Placental stem cell populations
ZA200509760B (en) Composition for maintaining organ and cell viability
MY148759A (en) Methods to culture circovirus
NO20033396D0 (no) Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter
DE69916807D1 (de) Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
WO2004096975A3 (en) Apparatus and methods for amplification of blood stem cell numbers
NO20030856D0 (no) Membranpenetrerende peptider og anvendelse av disse
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
WO2002010350A1 (en) Method of proliferating natural killer cells
GB2386905B (en) Carrier for cell culture and method for culturing cells
IL165969A0 (en) Medium for culturing aurologous human progenitor stem cells and applications thereof
AU2003280687A1 (en) Composition for culturing multipotent stem cells and utilization of the same
AU2003287521A1 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
WO2005068612A3 (en) Human hepatic progenitor cells and methods of use thereof
SI1743029T1 (sl) Priprava celic
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2005042732A3 (en) STABLE CELL LINES EXPRESSING HERG1a AND HERG1b
AU2003260815A8 (en) Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
AU2002246867A1 (en) The use of immature dendritic cells to silence antigen specific cd8+t cell function
AU2003274535A1 (en) Cell culture supplement for the in vitro cultivation of cells and a method for culturing cells
GB0201477D0 (en) Methods of obtaining isoform specific expression in mammalian cells
WO2004096972A3 (en) Apparatus and methods for amplification of blood stem cell numbers
AU2002344527A1 (en) The feeder cell layer for in vitro culturing human embryonic stem cells and the method for culturing embryonic stem cells